1.0% IP-001 for injection

DRUG2 trials

Sponsors

Immunophotonics, Inc., Robert C. Martin

Conditions

Colon CancerHepatocellular CarcinomaMetastatic Solid TumorNonsmall Cell Lung CancerSoft Tissue Sarcoma

Phase 1

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

Active, not recruitingNCT05688280

Immunophotonics, Inc.Colon Cancer, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer +1

Start: 2022-11-29End: 2025-02-28Updated: 2025-01-08

Phase 2

Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

RecruitingNCT06526338

Robert C. MartinHepatocellular Carcinoma

Start: 2024-07-24End: 2030-12-01Target: 315Updated: 2026-09-04